Growth kinetics of small renal mass: Initial analysis of active surveillance registry
To evaluate the clinical safety and natural history of active surveillance (AS) for incidentally diagnosed small renal mass (SRM). We analyzed prospective data for patients who underwent AS for SRM. From 2010 to 2016, 37 SRMs of less than 3 cm were registered. Computed tomography (CT) and magnetic r...
Saved in:
| Published in | Investigative and clinical urology Vol. 58; no. 6; pp. 429 - 433 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Korea (South)
The Korean Urological Association
01.11.2017
Korean Urological Association 대한비뇨의학회 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2466-0493 2466-054X 2466-054X |
| DOI | 10.4111/icu.2017.58.6.429 |
Cover
| Abstract | To evaluate the clinical safety and natural history of active surveillance (AS) for incidentally diagnosed small renal mass (SRM).
We analyzed prospective data for patients who underwent AS for SRM. From 2010 to 2016, 37 SRMs of less than 3 cm were registered. Computed tomography (CT) and magnetic resonance imaging were used for initial diagnosis and CT, ultrasonography, and chest CT were performed at 6-month intervals. If there was no change in size during 2 years, follow-ups were performed annually. If the growth rate was more than 0.5 cm/y, if the diameter was more than 4 cm, or if clinical progression was observed, we regarded it as progression of SRM and recommended active treatment. We compared the growth rate and clinical course of SRM between patients who remained on surveillance and those who had progressed disease.
The mean age was 63 years (range, 30-86 years) and the mean diameter was 1.8 cm (range, 0.6-2.8 cm) at diagnosis. The mean follow-up period was 27.3 months (range, 6-80 months) and the average growth rate was 0.2 cm/y (range, 0-1.9 cm/y). Six patients (16.2%) showed progression of SRM. Three patients wanted continuous observation, and partial nephrectomy was performed on 3 other patients. None of the patients had clinical progression, including metastasis.
We could delay active treatment for patients with an SRM with scheduled surveillance if the SRM grew relatively slowly. If more long-term AS results are documented for more patients, AS could be an alternative treatment modality for SRM. |
|---|---|
| AbstractList | To evaluate the clinical safety and natural history of active surveillance (AS) for incidentally diagnosed small renal mass (SRM).
We analyzed prospective data for patients who underwent AS for SRM. From 2010 to 2016, 37 SRMs of less than 3 cm were registered. Computed tomography (CT) and magnetic resonance imaging were used for initial diagnosis and CT, ultrasonography, and chest CT were performed at 6-month intervals. If there was no change in size during 2 years, follow-ups were performed annually. If the growth rate was more than 0.5 cm/y, if the diameter was more than 4 cm, or if clinical progression was observed, we regarded it as progression of SRM and recommended active treatment. We compared the growth rate and clinical course of SRM between patients who remained on surveillance and those who had progressed disease.
The mean age was 63 years (range, 30-86 years) and the mean diameter was 1.8 cm (range, 0.6-2.8 cm) at diagnosis. The mean follow-up period was 27.3 months (range, 6-80 months) and the average growth rate was 0.2 cm/y (range, 0-1.9 cm/y). Six patients (16.2%) showed progression of SRM. Three patients wanted continuous observation, and partial nephrectomy was performed on 3 other patients. None of the patients had clinical progression, including metastasis.
We could delay active treatment for patients with an SRM with scheduled surveillance if the SRM grew relatively slowly. If more long-term AS results are documented for more patients, AS could be an alternative treatment modality for SRM. Purpose: To evaluate the clinical safety and natural history of active surveillance (AS) for incidentally diagnosed small renal mass (SRM). Materials and Methods: We analyzed prospective data for patients who underwent AS for SRM. From 2010 to 2016, 37 SRMs of less than 3 cm were registered. Computed tomography (CT) and magnetic resonance imaging were used for initial diagnosis and CT, ultrasonography, and chest CT were performed at 6-month intervals. If there was no change in size during 2 years, follow-ups were performed annually. If the growth rate was more than 0.5 cm/y, if the diameter was more than 4 cm, or if clinical progression was observed, we regarded it as progression of SRM and recommended active treatment. We compared the growth rate and clinical course of SRM between patients who remained on surveillance and those who had progressed disease. Results: The mean age was 63 years (range, 30–86 years) and the mean diameter was 1.8 cm (range, 0.6–2.8 cm) at diagnosis. The mean follow-up period was 27.3 months (range, 6–80 months) and the average growth rate was 0.2 cm/y (range, 0–1.9 cm/y). Six patients (16.2%) showed progression of SRM. Three patients wanted continuous observation, and partial nephrectomy was performed on 3 other patients. None of the patients had clinical progression, including metastasis. Conclusions: We could delay active treatment for patients with an SRM with scheduled surveillance if the SRM grew relatively slowly. If more long-term AS results are documented for more patients, AS could be an alternative treatment modality for SRM. KCI Citation Count: 2 To evaluate the clinical safety and natural history of active surveillance (AS) for incidentally diagnosed small renal mass (SRM).PurposeTo evaluate the clinical safety and natural history of active surveillance (AS) for incidentally diagnosed small renal mass (SRM).We analyzed prospective data for patients who underwent AS for SRM. From 2010 to 2016, 37 SRMs of less than 3 cm were registered. Computed tomography (CT) and magnetic resonance imaging were used for initial diagnosis and CT, ultrasonography, and chest CT were performed at 6-month intervals. If there was no change in size during 2 years, follow-ups were performed annually. If the growth rate was more than 0.5 cm/y, if the diameter was more than 4 cm, or if clinical progression was observed, we regarded it as progression of SRM and recommended active treatment. We compared the growth rate and clinical course of SRM between patients who remained on surveillance and those who had progressed disease.Materials and MethodsWe analyzed prospective data for patients who underwent AS for SRM. From 2010 to 2016, 37 SRMs of less than 3 cm were registered. Computed tomography (CT) and magnetic resonance imaging were used for initial diagnosis and CT, ultrasonography, and chest CT were performed at 6-month intervals. If there was no change in size during 2 years, follow-ups were performed annually. If the growth rate was more than 0.5 cm/y, if the diameter was more than 4 cm, or if clinical progression was observed, we regarded it as progression of SRM and recommended active treatment. We compared the growth rate and clinical course of SRM between patients who remained on surveillance and those who had progressed disease.The mean age was 63 years (range, 30-86 years) and the mean diameter was 1.8 cm (range, 0.6-2.8 cm) at diagnosis. The mean follow-up period was 27.3 months (range, 6-80 months) and the average growth rate was 0.2 cm/y (range, 0-1.9 cm/y). Six patients (16.2%) showed progression of SRM. Three patients wanted continuous observation, and partial nephrectomy was performed on 3 other patients. None of the patients had clinical progression, including metastasis.ResultsThe mean age was 63 years (range, 30-86 years) and the mean diameter was 1.8 cm (range, 0.6-2.8 cm) at diagnosis. The mean follow-up period was 27.3 months (range, 6-80 months) and the average growth rate was 0.2 cm/y (range, 0-1.9 cm/y). Six patients (16.2%) showed progression of SRM. Three patients wanted continuous observation, and partial nephrectomy was performed on 3 other patients. None of the patients had clinical progression, including metastasis.We could delay active treatment for patients with an SRM with scheduled surveillance if the SRM grew relatively slowly. If more long-term AS results are documented for more patients, AS could be an alternative treatment modality for SRM.ConclusionsWe could delay active treatment for patients with an SRM with scheduled surveillance if the SRM grew relatively slowly. If more long-term AS results are documented for more patients, AS could be an alternative treatment modality for SRM. Purpose: To evaluate the clinical safety and natural history of active surveillance (AS) for incidentally diagnosed small renal mass (SRM). Materials and Methods: We analyzed prospective data for patients who underwent AS for SRM. From 2010 to 2016, 37 SRMs of less than 3 cm were registered. Computed tomography (CT) and magnetic resonance imaging were used for initial diagnosis and CT, ultrasonography, and chest CT were performed at 6-month intervals. If there was no change in size during 2 years, follow-ups were performed annually. If the growth rate was more than 0.5 cm/y, if the diameter was more than 4 cm, or if clinical progression was observed, we regarded it as progression of SRM and recommended active treatment. We compared the growth rate and clinical course of SRM between patients who remained on surveillance and those who had progressed disease. Results: The mean age was 63 years (range, 30–86 years) and the mean diameter was 1.8 cm (range, 0.6–2.8 cm) at diagnosis. The mean follow-up period was 27.3 months (range, 6–80 months) and the average growth rate was 0.2 cm/y (range, 0–1.9 cm/y). Six patients (16.2%) showed progression of SRM. Three patients wanted continuous observation, and partial nephrectomy was performed on 3 other patients. None of the patients had clinical progression, including metastasis. Conclusions: We could delay active treatment for patients with an SRM with scheduled surveillance if the SRM grew relatively slowly. If more long-term AS results are documented for more patients, AS could be an alternative treatment modality for SRM. |
| Author | Lee, Dong Hoon Nam, Jong Kil Lee, Seung Soo Chung, Moon Kee Park, Sung-Woo |
| AuthorAffiliation | Department of Urology, Pusan National University Yangsan Hospital, Yangsan, Korea |
| AuthorAffiliation_xml | – name: Department of Urology, Pusan National University Yangsan Hospital, Yangsan, Korea |
| Author_xml | – sequence: 1 givenname: Sung-Woo surname: Park fullname: Park, Sung-Woo organization: Department of Urology, Pusan National University Yangsan Hospital, Yangsan, Korea – sequence: 2 givenname: Seung Soo surname: Lee fullname: Lee, Seung Soo organization: Department of Urology, Pusan National University Yangsan Hospital, Yangsan, Korea – sequence: 3 givenname: Dong Hoon surname: Lee fullname: Lee, Dong Hoon organization: Department of Urology, Pusan National University Yangsan Hospital, Yangsan, Korea – sequence: 4 givenname: Jong Kil surname: Nam fullname: Nam, Jong Kil organization: Department of Urology, Pusan National University Yangsan Hospital, Yangsan, Korea – sequence: 5 givenname: Moon Kee surname: Chung fullname: Chung, Moon Kee organization: Department of Urology, Pusan National University Yangsan Hospital, Yangsan, Korea |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29124242$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002281143$$DAccess content in National Research Foundation of Korea (NRF) |
| BookMark | eNqFUU1v1DAUtFARLaU_gAvKEQ4b_G2HA1JVQVmpEhJqJW6W17G37ibxYjtb7b_H2bQV5QDywfbzzDzPm9fgaAiDBeAtgjVFCH30ZqwxRKJmsuY1xc0LcIIp5wvI6M-jxzNtyDE4S-kOQog4EYjIV-AYNwjTsk7AzWUM9_m22vjBZm9SFVyVet11VbSD7qpep_SpWg4--3LTpbRP_oDSJvudrdIYd9Z3nR6MLZy1Tznu34CXTnfJnj3sp-Dm65fri2-Lq--Xy4vzq4WhTZMXAhq6shYjiYgmsmFcUCo0Y4462a4QbDCCkLaYMaIlRg42RECEWmOxFC0mp-DDrDtEpzbGq6D9YV8HtYnq_Mf1UmEOJYWyYJcztg36Tm2j73XcHwiHQohrpWMZQWcVlsxJTJHhwtJGk1VrW-daJwTHiBlXtPCsNQ5bvb8v43oSRFBN8agSj5riUUwqrko8hfR5Jm3HVW-LhyFH3T37yfOXwd8WIztVxoIaPrl9_yAQw6_Rpqx6n4ydZm_DmFQBESwkxLxA3_3Z66nJY_AFIGaAiSGlaJ0yPuvsw9Tad_-0gf5i_t_6bzHi05I |
| CitedBy_id | crossref_primary_10_1007_s11934_018_0830_z crossref_primary_10_1097_MD_0000000000013102 crossref_primary_10_1007_s00345_020_03441_3 crossref_primary_10_1016_j_rx_2019_11_004 crossref_primary_10_1186_s12885_024_11941_3 crossref_primary_10_3390_ijms24097825 crossref_primary_10_1002_cncr_34896 crossref_primary_10_3233_KCA_230025 crossref_primary_10_1016_j_rxeng_2020_02_002 |
| Cites_doi | 10.2214/AJR.07.2724 10.1111/j.1442-2042.2012.03030.x 10.1016/j.juro.2006.04.047 10.1016/j.eururo.2009.10.023 10.1016/j.eururo.2010.06.032 10.1016/S0090-4295(03)00658-7 10.1016/j.eururo.2012.02.039 10.1016/j.eururo.2011.06.021 10.1016/j.juro.2006.08.013 10.1016/j.eururo.2011.02.023 10.1093/jnci/djj362 10.1016/j.juro.2013.08.074 10.1007/s11255-013-0389-z 10.1002/cncr.20025 10.1016/j.urology.2005.04.003 10.1002/cncr.23268 10.1016/j.eururo.2015.02.001 10.1016/j.urology.2010.09.031 10.1016/j.juro.2012.09.032 10.1016/j.juro.2006.06.005 10.1016/j.juro.2010.01.024 10.1016/j.eururo.2011.06.049 10.1016/j.eururo.2011.03.030 10.1016/j.urology.2008.04.054 10.1111/j.1464-410X.2006.06126.x 10.1111/j.1442-2042.2010.02525.x 10.1016/j.juro.2007.03.129 10.1111/bju.13630 10.1097/01.ju.0000095475.12515.5e |
| ContentType | Journal Article |
| Copyright | The Korean Urological Association, 2017 2017 The Korean Urological Association |
| Copyright_xml | – notice: The Korean Urological Association, 2017 2017 The Korean Urological Association |
| DBID | AAYXX CITATION NPM 7X8 5PM ADTOC UNPAY DOA ACYCR |
| DOI | 10.4111/icu.2017.58.6.429 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall DOAJ Directory of Open Access Journals Korean Citation Index |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2466-054X |
| EndPage | 433 |
| ExternalDocumentID | oai_kci_go_kr_ARTI_2608408 oai_doaj_org_article_285f8241c67e49a3bdedffdf776215cf 10.4111/icu.2017.58.6.429 PMC5671962 29124242 10_4111_icu_2017_58_6_429 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: ; |
| GroupedDBID | 5-W 8JR 9ZL AAYXX ABDBF ACUHS ADBBV ADRAZ ALMA_UNASSIGNED_HOLDINGS AOIJS BCNDV CITATION EBD ESX GROUPED_DOAJ HYE IPNFZ KQ8 M48 PGMZT RIG RPM TUS M~E NPM OK1 7X8 5PM ADTOC UNPAY ACYCR |
| ID | FETCH-LOGICAL-c499t-70c4bee21813a389567447a55f4f8db10921004d2553a821f0937011dce287d23 |
| IEDL.DBID | M48 |
| ISSN | 2466-0493 2466-054X |
| IngestDate | Sun Mar 09 07:51:00 EDT 2025 Wed Aug 27 01:24:35 EDT 2025 Sun Sep 07 10:56:44 EDT 2025 Thu Aug 21 14:05:45 EDT 2025 Fri Jul 11 04:07:07 EDT 2025 Wed Feb 19 02:44:00 EST 2025 Thu Apr 24 23:04:15 EDT 2025 Tue Jul 01 00:49:01 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Surveillance Kidney Neoplasms |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. cc-by-nc |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c499t-70c4bee21813a389567447a55f4f8db10921004d2553a821f0937011dce287d23 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.4111/icu.2017.58.6.429 |
| PMID | 29124242 |
| PQID | 1963278026 |
| PQPubID | 23479 |
| PageCount | 5 |
| ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_2608408 doaj_primary_oai_doaj_org_article_285f8241c67e49a3bdedffdf776215cf unpaywall_primary_10_4111_icu_2017_58_6_429 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5671962 proquest_miscellaneous_1963278026 pubmed_primary_29124242 crossref_citationtrail_10_4111_icu_2017_58_6_429 crossref_primary_10_4111_icu_2017_58_6_429 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2017-11-01 |
| PublicationDateYYYYMMDD | 2017-11-01 |
| PublicationDate_xml | – month: 11 year: 2017 text: 2017-11-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Korea (South) |
| PublicationPlace_xml | – name: Korea (South) |
| PublicationTitle | Investigative and clinical urology |
| PublicationTitleAlternate | Investig Clin Urol |
| PublicationYear | 2017 |
| Publisher | The Korean Urological Association Korean Urological Association 대한비뇨의학회 |
| Publisher_xml | – name: The Korean Urological Association – name: Korean Urological Association – name: 대한비뇨의학회 |
| References | Heuer (10.4111/icu.2017.58.6.429_ref7) 2010; 57 Vasudevan (10.4111/icu.2017.58.6.429_ref8) 2006; 97 Snyder (10.4111/icu.2017.58.6.429_ref24) 2006; 176 Mason (10.4111/icu.2017.58.6.429_ref3) 2011; 59 Prasad (10.4111/icu.2017.58.6.429_ref29) 2008; 190 Brunocilla (10.4111/icu.2017.58.6.429_ref9) 2013; 45 Hollingsworth (10.4111/icu.2017.58.6.429_ref17) 2006; 98 Schlomer (10.4111/icu.2017.58.6.429_ref27) 2006; 176 Haramis (10.4111/icu.2017.58.6.429_ref4) 2011; 77 Jewett (10.4111/icu.2017.58.6.429_ref21) 2011; 60 Volpe (10.4111/icu.2017.58.6.429_ref1) 2004; 100 Fujii (10.4111/icu.2017.58.6.429_ref6) 2008; 72 Halverson (10.4111/icu.2017.58.6.429_ref11) 2013; 189 Richard (10.4111/icu.2017.58.6.429_ref10) 2017; 119 Shuch (10.4111/icu.2017.58.6.429_ref14) 2014; 191 Ljungberg (10.4111/icu.2017.58.6.429_ref18) 2010; 58 Ljungberg (10.4111/icu.2017.58.6.429_ref16) 2011; 60 Pahernik (10.4111/icu.2017.58.6.429_ref5) 2007; 178 Frank (10.4111/icu.2017.58.6.429_ref28) 2003; 170 Soga (10.4111/icu.2017.58.6.429_ref23) 2012; 19 Xiong (10.4111/icu.2017.58.6.429_ref25) 2010; 17 Rosales (10.4111/icu.2017.58.6.429_ref2) 2010; 183 Crispen (10.4111/icu.2017.58.6.429_ref20) 2008; 112 Pierorazio (10.4111/icu.2017.58.6.429_ref13) 2015; 68 Leveridge (10.4111/icu.2017.58.6.429_ref12) 2011; 60 Israel (10.4111/icu.2017.58.6.429_ref15) 2005; 66 Remzi (10.4111/icu.2017.58.6.429_ref22) 2006; 176 Duchene (10.4111/icu.2017.58.6.429_ref26) 2003; 62 MacLennan (10.4111/icu.2017.58.6.429_ref19) 2012; 61 |
| References_xml | – volume: 190 start-page: 158 year: 2008 ident: 10.4111/icu.2017.58.6.429_ref29 publication-title: AJR Am J Roentgenol doi: 10.2214/AJR.07.2724 – volume: 19 start-page: 729 year: 2012 ident: 10.4111/icu.2017.58.6.429_ref23 publication-title: Int J Urol doi: 10.1111/j.1442-2042.2012.03030.x – volume: 176 start-page: 896 year: 2006 ident: 10.4111/icu.2017.58.6.429_ref22 publication-title: J Urol doi: 10.1016/j.juro.2006.04.047 – volume: 57 start-page: 223 year: 2010 ident: 10.4111/icu.2017.58.6.429_ref7 publication-title: Eur Urol doi: 10.1016/j.eururo.2009.10.023 – volume: 58 start-page: 398 year: 2010 ident: 10.4111/icu.2017.58.6.429_ref18 publication-title: Eur Urol doi: 10.1016/j.eururo.2010.06.032 – volume: 62 start-page: 827 year: 2003 ident: 10.4111/icu.2017.58.6.429_ref26 publication-title: Urology doi: 10.1016/S0090-4295(03)00658-7 – volume: 61 start-page: 972 year: 2012 ident: 10.4111/icu.2017.58.6.429_ref19 publication-title: Eur Urol doi: 10.1016/j.eururo.2012.02.039 – volume: 60 start-page: 578 year: 2011 ident: 10.4111/icu.2017.58.6.429_ref12 publication-title: Eur Urol doi: 10.1016/j.eururo.2011.06.021 – volume: 176 start-page: 2391 issue: 6 Pt 1 year: 2006 ident: 10.4111/icu.2017.58.6.429_ref24 publication-title: J Urol doi: 10.1016/j.juro.2006.08.013 – volume: 59 start-page: 863 year: 2011 ident: 10.4111/icu.2017.58.6.429_ref3 publication-title: Eur Urol doi: 10.1016/j.eururo.2011.02.023 – volume: 98 start-page: 1331 year: 2006 ident: 10.4111/icu.2017.58.6.429_ref17 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djj362 – volume: 191 start-page: 301 year: 2014 ident: 10.4111/icu.2017.58.6.429_ref14 publication-title: J Urol doi: 10.1016/j.juro.2013.08.074 – volume: 45 start-page: 307 year: 2013 ident: 10.4111/icu.2017.58.6.429_ref9 publication-title: Int Urol Nephrol doi: 10.1007/s11255-013-0389-z – volume: 100 start-page: 738 year: 2004 ident: 10.4111/icu.2017.58.6.429_ref1 publication-title: Cancer doi: 10.1002/cncr.20025 – volume: 66 start-page: 484 year: 2005 ident: 10.4111/icu.2017.58.6.429_ref15 publication-title: Urology doi: 10.1016/j.urology.2005.04.003 – volume: 112 start-page: 1051 year: 2008 ident: 10.4111/icu.2017.58.6.429_ref20 publication-title: Cancer doi: 10.1002/cncr.23268 – volume: 68 start-page: 408 year: 2015 ident: 10.4111/icu.2017.58.6.429_ref13 publication-title: Eur Urol doi: 10.1016/j.eururo.2015.02.001 – volume: 77 start-page: 787 year: 2011 ident: 10.4111/icu.2017.58.6.429_ref4 publication-title: Urology doi: 10.1016/j.urology.2010.09.031 – volume: 189 start-page: 441 year: 2013 ident: 10.4111/icu.2017.58.6.429_ref11 publication-title: J Urol doi: 10.1016/j.juro.2012.09.032 – volume: 176 start-page: 1317 issue: 4 Pt 1 year: 2006 ident: 10.4111/icu.2017.58.6.429_ref27 publication-title: J Urol doi: 10.1016/j.juro.2006.06.005 – volume: 183 start-page: 1698 year: 2010 ident: 10.4111/icu.2017.58.6.429_ref2 publication-title: J Urol doi: 10.1016/j.juro.2010.01.024 – volume: 60 start-page: 615 year: 2011 ident: 10.4111/icu.2017.58.6.429_ref16 publication-title: Eur Urol doi: 10.1016/j.eururo.2011.06.049 – volume: 60 start-page: 39 year: 2011 ident: 10.4111/icu.2017.58.6.429_ref21 publication-title: Eur Urol doi: 10.1016/j.eururo.2011.03.030 – volume: 72 start-page: 598 year: 2008 ident: 10.4111/icu.2017.58.6.429_ref6 publication-title: Urology doi: 10.1016/j.urology.2008.04.054 – volume: 97 start-page: 946 year: 2006 ident: 10.4111/icu.2017.58.6.429_ref8 publication-title: BJU Int doi: 10.1111/j.1464-410X.2006.06126.x – volume: 17 start-page: 517 year: 2010 ident: 10.4111/icu.2017.58.6.429_ref25 publication-title: Int J Urol doi: 10.1111/j.1442-2042.2010.02525.x – volume: 178 start-page: 414 year: 2007 ident: 10.4111/icu.2017.58.6.429_ref5 publication-title: J Urol doi: 10.1016/j.juro.2007.03.129 – volume: 119 start-page: 543 year: 2017 ident: 10.4111/icu.2017.58.6.429_ref10 publication-title: BJU Int doi: 10.1111/bju.13630 – volume: 170 start-page: 2217 issue: 6 Pt 1 year: 2003 ident: 10.4111/icu.2017.58.6.429_ref28 publication-title: J Urol doi: 10.1097/01.ju.0000095475.12515.5e |
| SSID | ssj0001637138 |
| Score | 2.0883827 |
| Snippet | To evaluate the clinical safety and natural history of active surveillance (AS) for incidentally diagnosed small renal mass (SRM).
We analyzed prospective data... To evaluate the clinical safety and natural history of active surveillance (AS) for incidentally diagnosed small renal mass (SRM).PurposeTo evaluate the... Purpose: To evaluate the clinical safety and natural history of active surveillance (AS) for incidentally diagnosed small renal mass (SRM). Materials and... Purpose: To evaluate the clinical safety and natural history of active surveillance (AS) for incidentally diagnosed small renal mass (SRM). Materials and... |
| SourceID | nrf doaj unpaywall pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 429 |
| SubjectTerms | Kidney Neoplasms Original Surveillance 비뇨기과학 |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD8AF8SbloYA4gbIkju0k3ABRWqRyYqXeLMcPutpttspuWvHv-SZJl12B6IVLoiS2lXjGnu-zJzOMvebGycL5OhGZxYFnITGZqRKeWRlSZYR0tKB__E0dTsXXE3myleqLfMKG8MBDx73jpQwlzIxVhReVyWvnXQguFBjFmbSBZl-YsS0y1a-uqBzsq09HJxQos6jyYUtTkBvPzHbk1FVMZDlRE9HDy99GqY_dD1PTtOFvsPNP78lbXXNufl6axWLLNB3cZXdGTBl_GL7lHrvhm_vs5vG4a_6ATb-Aa69P4zmuKCpzvAzx6gwNxa2nimcA0O_jI3IjwpUZw5RQKdPPhvGqay88pSeChsSUyoEyxD1k04PP3z8dJmM6hcSC1qyTIrWi9p5sem6AU6QqhCiMlEGE0tVZWnEKH-dAMnJTQmopoAuGPz4UtMrx_BHba5aNf8JirqogbYmiQGCmsjVwU-5qSlyuuMtExNKr_tR2jDVOKS8WGpyDRKAhAk0i0LLUSkMEEXuzqXI-BNr4V-GPJKRNQYqR3d-A5uhRc_R1mhOxVxCxnttZX5_OP5Z63mowiSMNngfuW0bs5ZUGaAw82k0xjV92K01TFy9KcNiIPR40YvM-vMrotxsesWJHV3ZeePdJMzvtg3tDKmgZNd9utOr6_tj_H_3xlN2mRocfLZ-xvXXb-edAXOv6RT-4fgGq5iXe priority: 102 providerName: Directory of Open Access Journals |
| Title | Growth kinetics of small renal mass: Initial analysis of active surveillance registry |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/29124242 https://www.proquest.com/docview/1963278026 https://pubmed.ncbi.nlm.nih.gov/PMC5671962 https://doi.org/10.4111/icu.2017.58.6.429 https://doaj.org/article/285f8241c67e49a3bdedffdf776215cf https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002281143 |
| UnpaywallVersion | publishedVersion |
| Volume | 58 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Investigative and Clinical Urology, 2017, 58(6), , pp.429-433 |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2466-054X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001637138 issn: 2466-0493 databaseCode: KQ8 dateStart: 20160101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2466-054X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001637138 issn: 2466-0493 databaseCode: DOA dateStart: 20160101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: Academic Search Ultimate - eBooks customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 2466-054X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001637138 issn: 2466-0493 databaseCode: ABDBF dateStart: 20160101 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVERR databaseName: KoreaMed Open Access customDbUrl: eissn: 2466-054X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001637138 issn: 2466-0493 databaseCode: 5-W dateStart: 20160101 isFulltext: true titleUrlDefault: https://koreamed.org/journals providerName: Korean Association of Medical Journal Editors – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2466-054X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001637138 issn: 2466-0493 databaseCode: RPM dateStart: 20160101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 2466-054X dateEnd: 20250930 omitProxy: true ssIdentifier: ssj0001637138 issn: 2466-0493 databaseCode: M48 dateStart: 20160601 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbGkIAXxHWEyxQQT6BUjWPnwgsCxNiQyhOV9mY5vmxVu2SkDbB_z3eStKKiAomXVmltN_U59vk-2_kOYy-5tjKzroxEbPDCYx_pWBcRj43041QLaWlBf_IlPZ6Kz6fydI-t01sNHbjcSe0on9S0WYx-frt6iwEP_DoSdCpnZlo6o5WNZD5KR5hgr7HrCEycnHwyoP1uySVNQMm6HHUiBY8WRdLvc-5uhXSCi5gen-BbQavT9kcoqhq_C5b-ebryZltd6qsferH4LXQd3WG3B8wZvuud5C7bc9U9dmMy7KrfZ9NP4OKr83COK1JtDmsfLi_QUNg4qngBgP0mPKFjRrjSg4wJldLdbBku2-a7o_RF8KCQUj1QBrkHbHr08euH42hItxAZ0J5VlI2NKJ2jmJ9o4BiZZkJkWkovfG7LeFxwkpezICGJzmHVMaANpgf8UdAuy5OHbL-qK_eIhTwtvDQ5igKh6cKUwFWJLSmxecptLAI2XvenMoMWOaXEWChwErKGgjUUWUPJXKUK1gjYq02Vy16I42-F35ORNgVJQ7v7oG7O1DAkFc-lz-EnJs2cKHRSWme9tz5DfIil8QF7AROruZl19en9rFbzRoFpnCjwQHDjPGDP1x6gMDBpt0VXrm6XiqY2nuXguAE76D1icz9rvwpYtuUrWze8_U01O-_Ev2EVtIyarzde9e_-ePzfv_OE3aKW-qcvn7L9VdO6Z4Bhq_KwW7447IbYL2jnLgg |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Growth+kinetics+of+small+renal+mass%3A+Initial+analysis+of+active+surveillance+registry&rft.jtitle=Investigative+and+clinical+urology&rft.au=Park%2C+Sung-Woo&rft.au=Lee%2C+Seung+Soo&rft.au=Lee%2C+Dong+Hoon&rft.au=Nam%2C+Jong+Kil&rft.date=2017-11-01&rft.pub=The+Korean+Urological+Association&rft.issn=2466-0493&rft.eissn=2466-054X&rft.volume=58&rft.issue=6&rft.spage=429&rft.epage=433&rft_id=info:doi/10.4111%2Ficu.2017.58.6.429&rft_id=info%3Apmid%2F29124242&rft.externalDocID=PMC5671962 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2466-0493&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2466-0493&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2466-0493&client=summon |